Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Stocks That Could Be Monster Winners in 2024


Finding stocks that are huge winners is easy, in retrospect. Doing so before they take off is an entirely different story. However, it's not an impossible task.

Three Motley Fool contributors think they've identified stocks that could be monster winners in 2024. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Madrigal Pharmaceuticals (NASDAQ: MDGL), and Verona Pharma (NASDAQ: VRNA).

Prosper Junior Bakiny (CRISPR Therapeutics): It's been a great year for the field of gene editing. Several companies that specialize in this area have made important progress. However, the most significant milestone arguably came from CRISPR Therapeutics, which, together with its partner Vertex Pharmaceuticals, earned approval for Casgevy.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Stock

€460.15
1.030%
There is an upward development for Vertex Pharmaceuticals Inc. compared to yesterday, with an increase of €4.70 (1.030%).
With 55 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
However, we have a potential of -2.21% for Vertex Pharmaceuticals Inc. as the target price of 450 € is below the current price of 460.15 €.
Like: 0
Share

Comments